Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
Authors
Keywords
Autoimmune systemic diseases, COVID-19 vaccine, Neutralizing antibodies, Systemic sclerosis, Rheumatoid arthritis, Systemic lupus, Cryoglobulinemic vasculitis, Systemic vasculitis
Journal
JOURNAL OF AUTOIMMUNITY
Volume 125, Issue -, Pages 102744
Publisher
Elsevier BV
Online
2021-11-10
DOI
10.1016/j.jaut.2021.102744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
- (2021) Michael Markus Bonelli et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series
- (2021) Caoilfhionn M. Connolly et al. ANNALS OF INTERNAL MEDICINE
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response
- (2021) Fredrik N Albach et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
- (2021) Clodoveo Ferri et al. CURRENT PHARMACEUTICAL DESIGN
- Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
- (2021) Raffaele D'Amelio et al. Biomedicines
- Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
- (2021) Andrea Rubbert-Roth et al. Lancet Rheumatology
- Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
- (2021) Matthias B Moor et al. Lancet Rheumatology
- Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
- (2021) Alessandro Antonelli et al. Lancet Rheumatology
- COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
- (2021) Filippo Fagni et al. Lancet Rheumatology
- Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination
- (2021) Sarah Frey et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
- (2020) Dalifer D Freites Nuñez et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
- (2020) Clodoveo Ferri et al. CLINICAL RHEUMATOLOGY
- COVID‐19 Outcomes in Patients with Systemic Autoimmune Rheumatic Diseases (SARDs) Compared to the General Population: A US Multi‐Center Comparative Cohort Study
- (2020) Kristin M. D’Silva et al. Arthritis & Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started